Former FDA commissioner anticipates 'persistent spread' of coronavirus, 100,000 deaths in U.S. by end of June
Former Food and Drug Administration commissioner Scott Gottleib, who's become a regular guest on CBS' Face the Nation, told host Margaret Brennan on Sunday that while coronavirus cases are no longer growing at an exponential rate in the United States, the country may have to prepare for "persistent spread," in which there are somewhere between 20,000 and 30,000 new infections and 1,000 new deaths, per day.
Gottleib didn't want to look beyond the end of June because it's too hard to predict (though he does expect a bit of reprieve later in the summer before potential flare-ups in the fall), but for now he doesn't seem optimistic that the decline will be as fast as the rise was in March. That means by the end of June, there could be more than 100,000 COVID-19 deaths in the country.
He also cautioned that the national decline can be misleading since it relies so heavily on the New York City metro area, which is indeed trending downward, but because the outbreak there was so large, it masks smaller outbreaks across the rest of the country. Tim O'Donnell
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
How to invest in the artificial intelligence boomThe Explainer Artificial intelligence is the biggest trend in technology, but there are fears that companies are overvalued
-
The Week Unwrapped: Are British rappers the world’s best?Podcast Plus can the Maldives quit smoking? And can whales lead us to immortality?
-
The week’s best photosIn Pictures A leap through the leaves, a typhoon's aftermath, and more
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
